Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization

Published:2024-06 Issue:5 Volume:1870 Page:167156
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Kumar Aman,Nagasaka Yosuke,Jayananthan Vinodhini,Zidan Asmaa,Heisler-Taylor Tyler,Ambati Jayakrishna,Tamiya Shigeo,Kerur Nagaraj

Funder

NIH

Ohio State University

Ohio Lions Eye Research Foundation

Research to Prevent Blindness

University of Virginia

Publisher

Elsevier BV

Reference57 articles.

1. Expression and role of VEGF--a in the ciliary body;Ford;Invest. Ophthalmol. Vis. Sci.,2012

2. Targeted deletion of Vegfa in adult mice induces vision loss;Kurihara;J. Clin. Invest.,2012

3. Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury;Nishijima;Am. J. Pathol.,2007

4. CCR3 is a target for age-related macular degeneration diagnosis and therapy;Takeda;Nature,2009

5. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results;Comparison of Age-related Macular Degeneration Treatments Trials Research, G;Ophthalmology,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP